SCN2A and autism spectrum disorder: Pathogenic SCN2A variants are associated with childhood-onset epilepsy of varying severity as well as autism spectrum disorder (ASD) with or without accompanying seizures and nonsyndromic intellectual disability (ID; Sanders et al., 2018; Hedrich et al., 2019; Wolff et al., 2019; Meisler et al., 2021).